Correction: Functional analysis of distinct factors linked to the development of latent to active tuberculosis
Frontiers in Cellular and Infection Microbiology · 10.03.2026 · 16
DOI: 10.3389/fcimb.2026.1817346 ↗Kurz gefasst
Korrektur in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 10.03.2026. Verfasst von Karthikeyan Sundaram und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Herbal Pharmacology and Environmental Sustainability, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Educ…. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SRM Institute of Science and Technology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Herbal Pharmacology and Environmental Sustainability, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Chennai, Tamilnadu, India.
- Division of Medical Research, SRM Medical College Hospital and Research Centre, Kattankulathur, Chennai, Tamilnadu, India.
Förderung
- SRM Institute of Science and Technology
Zitieren
APA
Sundaram, K., & Prabhu, V. (2026). Correction: Functional analysis of distinct factors linked to the development of latent to active tuberculosis. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1817346
Vancouver
Sundaram K, Prabhu V. Correction: Functional analysis of distinct factors linked to the development of latent to active tuberculosis. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1817346
BibTeX
@article{Sundaram2026,
author = {Sundaram, Karthikeyan and Prabhu, Venkataraman},
title = {Correction: Functional analysis of distinct factors linked to the development of latent to active tuberculosis},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1817346}
}
EUVIMED